Filing Flows › Industrials › Pharmaceutical Resource Technology
Pharmaceutical Resource Technology earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 4, 2026
Q3 2026 Revenue up 44% year over year to $3.3M · 14¢ of every $1 of revenue kept as net profit · operating margin 14.2%
Pharmaceutical Resource Technology made $3.3M in Q3 2026 (+44% Y/Y). Operating margin 14.2%, net earnings $455K. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 4, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $3.3M in Q3 2026, up 44% year over year and up 12% from the previous quarter.
Gross margin was 50.1%, up 3.7 points from a year earlier. Operating profit was $461K, a 14.2% margin (up 30.8 points year over year). Operating expenses fell 18% while revenue rose 44%. Net earnings were $455K. The effective tax rate was 1.3%.
Operating cash flow was $1.6M (up 378% year over year), 345% of net earnings. Non-cash charges added back $404K of depreciation and amortization. Working capital and other items added $713K. Capital expenditures of $4K left free cash flow of $1.6M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 4, 2026 | $3.3M | +44% | 14.2% | $455K | $1.6M |
| Q2 2026 | 10-Q | Aug 3, 2026 | $2.9M | -4% | 9.4% | $274K | — |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
About Pharmaceutical Resource Technology
The Company – Pharmaceutical Resource Technology, Inc., (the “Company”) is a Wyoming corporation. The Company conducts its primary business operations through activities located outside the United States, principally in Singapore, in the business of manufacturing dietary health supplements, skin care products and honey straws in Singapore. Although these products are produced in Singapore, they are sold through online portals and distributors throughout the Asia region. The company also operates a building and construction business in Singapore which caters to new building design and construction, interior design and renovation, alteration and addition of existing building and structure.
In its own words, from its 10-Q, filed Aug 3, 2026.
Pharmaceutical Resource Technology against its General Bldg Contractors - Nonresidential Bldgs peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +44% against the peers' median +44%. Operating margin: 14.2% against the peers' median 7.3%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| Pharmaceutical Resource Technology | Q3 2026 | $3.3M | +44% | 14.2% |
| TPC Tutor Perini | Q3 2026 | $1.7B | +22% | 7.3% |
| JFB Construction | Q2 2026 | $9.1M | +146% | -45.0% |
Source: Pharmaceutical Resource Technology 10-Q on SEC EDGAR · CIK 1865759 · General Bldg Contractors - Nonresidential Bldgs